by rss feed | Dec 4, 2025 | Capricor, clinical trials, Deramiocel, News Feeds
The cell therapy biotech Capricor just released new Phase 3 data from its Duchenne Muscular Dystrophy (DMD) program The firm is trialing its stromal cell product deramiocel for DMD. These new results are very encouraging and stronger than past data. Why am I excited...
by rss feed | Nov 8, 2024 | biotechs, Capricor, Deramiocel, Linda Marban, News Feeds
The cell therapy biotech Capricor recently released new data from their Duchenne Muscular Dystrophy (DMD) trial work. The data have generated excitement in the patient advocacy community. The stock has skyrocketed. How exciting are these new data? CEO Linda Marbán is...
